Baffled and rejected lutein players: 'EFSA did not evaluate our eye claim'
date:Jun 09, 2012
an effect

The lutein sector was pinning its hopes on the main addition in the resubmission - a study (LUXEA) of zeaxanthin and lutein supplements, and their accumulation in the eye.

But in dismissing it, the NDA observed,that the visual performance study was not randomised, that no information was provided on how subjects were selected from the LUXEA study, that the statistical methods used for data analysis are poorly described in the publications, and that no information is provided about t
6/9 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/15 22:21